We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase II Study of Clofarabine in Pediatric Acute Myelogenous Leukemia (AML) Patients

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00042354
First Posted: August 1, 2002
Last Update Posted: March 5, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Sanofi
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2004
  Primary Completion Date: No date given